Valentina Danesi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Prognostic Factors

Ejection Fraction

Small Cell Lung Cancer

Top Venues

Human vaccines & immunotherapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Nicola Gentili, William Balzi, Flavia Foca, Valentina Danesi, Mattia Altini, Angelo Delmonte, Giuseppe Bronte, Lucio Crinò, Nicoletta De Luigi, Marita Mariotti, Alberto Verlicchi, Marco Angelo Burgio, Andrea Roncadori, Thomas Burke, Oriana Nanni
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients. Cancers 16 (3) (2024)
Nicola Gentili, William Balzi, Flavia Foca, Valentina Danesi, Mattia Altini, Angelo Delmonte, Giuseppe Bronte, Lucio Crinò, Nicoletta De Luigi, Marita Mariotti, Alberto Verlicchi, Marco Angelo Burgio, Andrea Roncadori, Thomas Burke, Oriana Nanni
Healthcare Costs and Resource Utilisation of Italian Metastatic Non-Small Cell Lung Cancer Patients. Cancers 16 (3) (2024)
Valentina Danesi, Oriana Nanni, Flavia Foca, Angelo Delmonte, Lucio Crinò, Giuseppe Bronte, Maria Ragonesi, Roberta Maltoni, Silvia Manunta, Paola Cravero, Kalliopi Andrikou, Ilaria Priano, William Balzi, Nicola Gentili, Thomas Burke, Mattia Altini
Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer. Cancers 14 (18) (2022)
Lucia Bertoni, Andrea Roncadori, Nicola Gentili, Valentina Danesi, Oriana Nanni, Oriana Nanni, Mattia Altini, Giovanni Gabutti, Maria Teresa Montella
How has COVID-19 pandemic changed flu vaccination attitudes among an Italian cancer center healthcare workers? Human vaccines & immunotherapeutics (2021)
William Balzi, Andrea Roncadori, Valentina Danesi, Ilaria Massa, Silvia Manunta, Nicola Gentili, Angelo Delmonte, Lucio Crinò, Mattia Altini
How to discriminate non-small cell lung cancer (NSCLC) cases from an Italian administrative database? A retrospective, secondary data use study for evaluating a novel algorithm performance. BMJ open 11 (9) (2021)